Giant-cell tumor of bone: treatment options and role of denosumab

Por Singh, Arun S, Chawla, Neal S, Chawla, Sant P
Publicado no Biologics (2015)

Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives

Por Gordon, Erlinda M., Sankhala, K. Kumar, Chawla, Neal, Chawla, Sant P.
Publicado no Adv Ther (2016)

Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide

Por Chawla, Sant P, Staddon, Arthur, Hendifar, Andrew, Messam, Conrad A, Patwardhan, Rita, Kamel, Yasser Mostafa
Publicado em 2013

Advanced Phase I/II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Gemcitabine-resistant Metastatic Pancreatic Cancer

Por Chawla, Sant P, Chua, Victoria S, Fernandez, Lita, Quon, Dorris, Blackwelder, William C, Gordon, Erlinda M, Hall, Frederick L
Publicado em 2009

Phase I/II and Phase II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Chemotherapy-resistant Sarcoma and Osteosarcoma

Por Chawla, Sant P, Chua, Victoria S, Fernandez, Lita, Quon, Doris, Saralou, Andreh, Blackwelder, William C, Hall, Frederick L, Gordon, Erlinda M
Publicado em 2009

Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab

Por Tabernero, Josep, Chawla, Sant P., Kindler, Hedy, Reckamp, Karen, Chiorean, E. Gabriela, Azad, Nilofer S., Lockhart, A. Craig, Hsu, Cheng-Pang, Baker, Nigel F., Galimi, Francesco, Beltran, Pedro, Baselga, José
Publicado no Target Oncol (2014)

Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma

Por Chawla, Sant P., Cranmer, Lee D., Van Tine, Brian A., Reed, Damon R., Okuno, Scott H., Butrynski, James E., Adkins, Douglas R., Hendifar, Andrew E., Kroll, Stew, Ganjoo, Kristen N.
Publicado no J Clin Oncol (2014)

R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Al...

Por Pappo, Alberto S., Patel, Shreyaskumar R., Crowley, John, Reinke, Denise K., Kuenkele, Klaus-Peter, Chawla, Sant P., Toner, Guy C., Maki, Robert G., Meyers, Paul A., Chugh, Rashmi, Ganjoo, Kristen N., Schuetze, Scott M., Juergens, Heribert, Leahy, Michael G., Geoerger, Birgit, Benjamin, Robert S., Helman, Lee J., Baker, Laurence H.
Publicado em 2011